The key finding from the present study is that acetate as HDAC inhibitor attenuates defective hypothalamic-adipose metabolic network in HFD-induced obesity and this beneficial effect of acetate is accompanied by elevated PPAR-γ and suppressed oxidative stress. The gene discussed is PPARG; the disease is Obesity.